Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029015 · ClinicalTrials.gov registry record
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
A clinical trial of Bladder Function, sponsored by Astellas Pharma.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT01029015: Completed study of Bladder Function, sponsored by Astellas Pharma.
NCT01029015 is a study of Bladder Function that has completed, run by Astellas Pharma. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01029015, a study of Bladder Function, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational, physiology pilot study of subjects with overactive bladder, insomnia and normal subjects. No study drug will be given. All subjects will complete a one week sleep diary and a 3-day bladder diary. After one week, subjects meeting eligibility requirements will complete a single sleep night stay in a sleep laboratory setting. During the sleep night stay, subjects will be evaluated using cystometry and polysomnography. In the morning following the sleep night stay, subjects will complete a sleep questionnaire and this will complete their participation in the study.
Conditions Studied
Interventions
- PROCEDURE cystometry
- PROCEDURE polysomnography
Study Locations (1)
North Carolina
- - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-07 |
What the finished NCT01029015 record still lists
NCT01029015 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 1 condition, with Bladder Function appearing as the primary indexed condition, and to 2 interventions - of which cystometry is the first listed.
NCT01029015 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01029015 about?
NCT01029015 is a clinical study titled "Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects". This is an observational, physiology pilot study of subjects with overactive bladder, insomnia and normal subjects. No study drug will be given. All subjects will complete a one week sleep diary and a 3-day bladder diary. After one week, subjects meeting eligibility requirements will complete a sing...
What is the current status of trial NCT01029015?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2006-11. Estimated completion is 2007-07.
What conditions does trial NCT01029015 study?
This clinical trial studies the following conditions: Bladder Function.
What interventions are being tested in trial NCT01029015?
The interventions under investigation include: cystometry (PROCEDURE), polysomnography (PROCEDURE).
Who is sponsoring clinical trial NCT01029015?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01029015 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia